Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 2
2011 4
2012 4
2013 2
2014 4
2015 1
2017 6
2018 6
2019 9
2020 8
2021 5
2022 6
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation.
Eitler J, Rackwitz W, Wotschel N, Gudipati V, Murali Shankar N, Sidorenkova A, Huppa JB, Ortiz-Montero P, Opitz C, Künzel SR, Michen S, Temme A, Loureiro LR, Feldmann A, Bachmann M, Boissel L, Klingemann H, Wels WS, Tonn T. Eitler J, et al. Among authors: feldmann a. J Immunother Cancer. 2024 Feb 27;12(2):e008155. doi: 10.1136/jitc-2023-008155. J Immunother Cancer. 2024. PMID: 38417916 Free PMC article.
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype.
Towers R, Trombello L, Fusenig M, Tunger A, Baumann AL, Savoldelli R, Wehner R, Fasslrinner F, Arndt C, Dazzi F, Von Bonin M, Feldmann A, Bachmann MP, Wobus M, Schmitz M, Bornhäuser M. Towers R, et al. Among authors: feldmann a. Cancer Immunol Immunother. 2024 Jan 17;73(1):8. doi: 10.1007/s00262-023-03594-1. Cancer Immunol Immunother. 2024. PMID: 38231344 Free PMC article.
Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells.
Soto KEG, Loureiro LR, Bartsch T, Arndt C, Kegler A, Mitwasi N, Drewitz L, Hoffmann L, Saleh HA, Crespo E, Mehnert M, Daglar C, Abken H, Momburg F, Bachmann M, Feldmann A. Soto KEG, et al. Among authors: feldmann a. Front Immunol. 2023 Dec 15;14:1302354. doi: 10.3389/fimmu.2023.1302354. eCollection 2023. Front Immunol. 2023. PMID: 38169746 Free PMC article.
Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment.
Loureiro LR, Hoffmann L, Neuber C, Rupp L, Arndt C, Kegler A, Kubeil M, Hagemeyer CE, Stephan H, Schmitz M, Feldmann A, Bachmann M. Loureiro LR, et al. Among authors: feldmann a. J Exp Clin Cancer Res. 2023 Dec 15;42(1):341. doi: 10.1186/s13046-023-02912-w. J Exp Clin Cancer Res. 2023. PMID: 38102692 Free PMC article.
Correction to Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies.
Sandoval Bojórquez DI, Janićijević Ž, Romero BP, Oliveros Mata ES, Laube M, Feldmann A, Kegler A, Drewitz L, Fowley C, Pietzsch J, Fassbender J, Tonn T, Bachmann M, Baraban L. Sandoval Bojórquez DI, et al. Among authors: feldmann a. ACS Sens. 2023 Sep 22;8(9):3604. doi: 10.1021/acssensors.3c01503. Epub 2023 Aug 24. ACS Sens. 2023. PMID: 37616167 Free PMC article. No abstract available.
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells.
Kegler A, Drewitz L, Arndt C, Daglar C, Rodrigues Loureiro L, Mitwasi N, Neuber C, González Soto KE, Bartsch T, Baraban L, Ziehr H, Heine M, Nieter A, Moreira-Soto A, Kühne A, Drexler JF, Seliger B, Laube M, Máthé D, Pályi B, Hajdrik P, Forgách L, Kis Z, Szigeti K, Bergmann R, Feldmann A, Bachmann M. Kegler A, et al. Among authors: feldmann a. Front Immunol. 2023 Jun 13;14:1204543. doi: 10.3389/fimmu.2023.1204543. eCollection 2023. Front Immunol. 2023. PMID: 37383226 Free PMC article.
70 results